Novel Hyp-Gly-containing antiplatelet peptides from collagen hydrolysate after simulated gastrointestinal digestion and intestinal absorption.

Food & Function
Hongdong SongBo Li

Abstract

Bioactive components causing the antiplatelet activity upon collagen hydrolysate (CH) ingestion have not been clarified yet. This study aimed to identify antiplatelet peptides from CH after simulated gastrointestinal digestion and intestinal absorption. Four antiplatelet peptides containing the Hyp-Gly (OG) sequence including OG, Hyp-Gly-Glu (OGE), Pro-Gly-Glu-Hyp-Gly (PGEOG) and Val-Gly-Pro-Hyp-Gly-Pro-Ala (VGPOGPA) were successfully identified. All four peptides exhibited antiplatelet activity, but OGE and PGEOG exerted stronger activity than OG and VGPOGPA. The IC50 value of OGE and PGEOG was 1.076 mM and 1.167 mM, respectively. These four antiplatelet peptides could survive simulated gastrointestinal digestion and be absorbed intact by Caco-2 cells. Furthermore, plasma stability experiments showed that OG and OGE showed a good stability in human plasma, but PGEOG and VGPOGPA showed a relatively poor stability. In vivo studies indicated that OG and OGE were present in blood after the oral administration of CH. Meanwhile, OGE exerted significant in vivo anti-thrombotic activity after its ingestion. The present study clarifies the antiplatelet components causing the CH activity and highlights the potential application of CH or...Continue Reading

References

Jun 1, 1992·The Biochemical Journal·S HowellA J Turner
May 10, 2002·Bioscience, Biotechnology, and Biochemistry·Makoto SatakeMakoto Shimizu
Dec 18, 2004·Blood Reviews·Paul Harrison
Jan 7, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·Renato BruniGiorgio Koch
Apr 20, 2006·Amino Acids·M Werle, A Bernkop-Schnürch
Oct 20, 2006·Current Opinion in Biotechnology·Aaron K SatoClive R Wood
Oct 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-ShawNihal Ahmad
Mar 25, 2008·The American Journal of Cardiology·Gregory PiazzaSamuel Z Goldhaber
Oct 22, 2008·Thrombosis Research·Muneshige ShimizuJunichiro Yamamoto
Jun 2, 2009·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Melinda PhangAndrew J Sinclair
Apr 2, 2011·Seminars in Thrombosis and Hemostasis·Melinda PhangManohar Garg
Nov 2, 2011·Journal of Bioscience and Bioengineering·Fumihito SugiharaMakoto Taniguchi
Jan 10, 2013·Journal of Agricultural and Food Chemistry·Satyanarayana Bejjani, Jianping Wu
Jan 13, 2015·Phytotherapy Research : PTR·Anikisetty MaheswaraiahKamatham Akhilender Naidu
Feb 7, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sourav MajumdarAshis K Mukherjee
Sep 4, 2015·Journal of Agricultural and Food Chemistry·Long DingJingbo Liu
Feb 18, 2016·International Journal of Food Sciences and Nutrition·Long DingJingbo Liu
Apr 17, 2017·European Journal of Pharmacology·Caterina FaggioSeyed Mohammad Nabavi
Jan 1, 1997·Bioscience, Biotechnology, and Biochemistry·Isao NonakaSusumu Maruyama
Sep 16, 2017·Journal of the Science of Food and Agriculture·Yasutaka ShigemuraKenji Sato
Nov 17, 2017·Journal of Cosmetic Dermatology·María Isabela Avila RodríguezMirna Lorena Sánchez

❮ Previous
Next ❯

Methods Mentioned

BETA
blood

Software Mentioned

SPSS Statistics
BLAST search
PeptideCutter
Thermo Xcalibur

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.